Singulair Warning Upgraded
Mar 10, 2020 ·
1m 4s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Vidcast: https://youtu.be/P8V4d3XQpQ4 The FDA has ordered an upgrade of the warnings for montelukast, branded as Singulair and sold as a generic product as well. This drug can trigger dangerous mind-altering...
show more
Vidcast: https://youtu.be/P8V4d3XQpQ4 The FDA has ordered an upgrade of the warnings for montelukast, branded as Singulair and sold as a generic product as well. This drug can trigger dangerous mind-altering side effects including suicidal thoughts and actions. This drug is used by children and adults for management of allergies and asthma. It is used for seasonal allergic rhinitis for those 2 years and older and for exercise-induced asthma for those 6 years and older. The FDA recommends that parents and patients using this drug be aware of the risks and speak with doctors about alternative medications. Those with pre-existing psychiatric illness should not use the drug. Please report any and all adverse effects while using montelukast Singuair to the FDA at 1-800-332-1088. https://www.fda.gov/safety/medical-product-safety-information/singulair-montelukast-and-all-montelukast-generics-strengthened-boxed-warning-due-restricting-use #warning #suicide #depression #singulair #montelukast #allergy #asthma
show less
Information
Author | Howard G. Smith MD |
Organization | Howard G. Smith MD |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company